Penserra Capital Management LLC Passage Bio, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$6.24 - $10.2 $7,706 - $12,597	-1,235 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $48 - $77	5 Added 0.41%	1,235 $12,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $435 - $680	35 Added 2.93%	1,230 $16,000
Q1 2021 May 13, 2021	BUY	$16.24 - $29.83 $2,435 - $4,474	150 Added 14.35%	1,195 $20,000
Q4 2020 Feb 12, 2021	BUY	$14.28 - $29.73 $14,922 - $31,067	1,045 New	1,045 $26,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.